Impact of Patisiran, an RNAi Therapeutic, on Orthostatic Intolerance in Patients With Hereditary Transthyretin-Mediated Amyloidosis

Journal of Cardiac Failure - United States
doi 10.1016/j.cardfail.2019.07.222

Related search